Group | Drugs |
---|---|
1: First-line oral agents | Isoniazid, rifampicin, ethambutol, pyrazinamide, rifabutin, rifapentine |
2: Injectable anti-TB drugs | Streptomycin, kanamycin, amikacin, capreomycin |
3: Fluoroquinolones | Levofloxacin, moxifloxacin, gatifloxacin |
4: Oral bacteriostatic second-line anti-TB drugs | Ethionamide, prothionamide, cycloserine, terizidone para-aminosalicylic acid, para-aminosalicylate sodium |
5: Anti-TB drugs with limited data on efficacy and/or long-term safety in the treatment of drug-resistant TB | Bedaquiline, delamanid, linezolid, clofazimine, amoxicillin/clavulanate, imipenem/cilastatin, meropenem, high-dose isoniazid, thioacetazone, clarithromycin |
TB = tuberculosis; WHO = World Health Organization.